Zyrtec-D Paragraph IV Application Submitted To FDA
This article was originally published in The Tan Sheet
Executive Summary
A generic version of Pfizer's Zyrtec-D 12 Hour is among the Paragraph IV abbreviated new drug applications submitted to FDA early this summer
You may also be interested in...
Orally Dissolving Strips To Melt Away Heartburn? ANDA Suitability Sought
An orally disintegrating strip form of Johnson & Johnson/Merck's Pepcid AC (famotidine 10 mg) could be heading towards the market if FDA looks favorably upon a pending ANDA suitability petition
Orally Dissolving Strips To Melt Away Heartburn? ANDA Suitability Sought
An orally disintegrating strip form of Johnson & Johnson/Merck's Pepcid AC (famotidine 10 mg) could be heading towards the market if FDA looks favorably upon a pending ANDA suitability petition
Orally Dissolving Strips To Melt Away Heartburn? ANDA Suitability Sought
An orally disintegrating strip form of Johnson & Johnson/Merck's Pepcid AC (famotidine 10 mg) could be heading towards the market if FDA looks favorably upon a pending ANDA suitability petition